Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05983276
Title Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Loyola University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.